Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures and markets products for pets and farm animals. The company is headquartered in Greenfield, Indiana.
| Revenue (TTM) | $4.71B |
| Gross Profit (TTM) | $2.59B |
| EBITDA | $908.00M |
| Operating Margin | 2.27% |
| Return on Equity | -3.67% |
| Return on Assets | 1.25% |
| Revenue/Share (TTM) | $9.50 |
| Book Value | $13.17 |
| Price-to-Book | 1.81 |
| Price-to-Sales (TTM) | 2.51 |
| EV/Revenue | 3.244 |
| EV/EBITDA | 22.63 |
| Quarterly Earnings Growth (YoY) | 116.70% |
| Quarterly Revenue Growth (YoY) | 12.20% |
| Shares Outstanding | $499.38M |
| Float | $492.68M |
| % Insiders | 1.19% |
| % Institutions | 109.38% |
Volatility is currently contracting